| Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells H Shaim, M Shanley, R Basar, M Daher, J Gumin, DB Zamler, N Uprety, ... The Journal of Clinical Investigation 131 (14), 2021 | 159 | 2021 |
| Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications J Wei, P Chen, P Gupta, M Ott, D Zamler, C Kassab, KP Bhat, MA Curran, ... Neuro-oncology 22 (2), 180-194, 2020 | 159 | 2020 |
| Comparative molecular life history of spontaneous canine and human gliomas SB Amin, KJ Anderson, CE Boudreau, E Martinez-Ledesma, E Kocakavuk, ... Cancer cell 37 (2), 243-257. e7, 2020 | 74 | 2020 |
| Verteporfin inhibits PD-L1 through autophagy and the STAT1–IRF1–TRIM28 signaling axis, exerting antitumor efficacy J Liang, L Wang, C Wang, J Shen, B Su, AL Marisetty, D Fang, C Kassab, ... Cancer immunology research 8 (7), 952-965, 2020 | 73 | 2020 |
| ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma VA Arrieta, AX Chen, JR Kane, SJ Kang, C Kassab, C Dmello, J Zhao, ... Nature cancer 2 (12), 1372-1386, 2021 | 63 | 2021 |
| Radiation with STAT3 blockade triggers dendritic cell–T cell interactions in the glioma microenvironment and therapeutic efficacy M Ott, C Kassab, A Marisetty, Y Hashimoto, J Wei, D Zamler, JS Leu, ... Clinical Cancer Research 26 (18), 4983-4994, 2020 | 49 | 2020 |
| Glioblastoma-mediated immune dysfunction limits CMV-specific T cells and therapeutic responses: results from a phase I/II trial SP Weathers, M Penas-Prado, BL Pei, X Ling, C Kassab, P Banerjee, ... Clinical Cancer Research 26 (14), 3565-3577, 2020 | 38 | 2020 |
| A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma J Groot, M Ott, J Wei, C Kassab, D Fang, H Najem, B O’Brien, ... CNS oncology 11 (2), CNS87, 2022 | 34 | 2022 |
| Immune landscape of a genetically engineered murine model of glioma compared with human glioma DB Zamler, T Shingu, LM Kahn, K Huntoon, C Kassab, M Ott, K Tomczak, ... JCI insight 7 (12), 2022 | 12 | 2022 |
| Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression H Najem, M Ott, C Kassab, A Rao, G Rao, A Marisetty, AM Sonabend, ... JCI insight 7 (9), 2022 | 12 | 2022 |
| Sugammadex‐Associated Hypotension, Bradycardia, Asystole, and Death K Mirza, K Landoski, D Thakar, J Heir-Singh, T Jackson, C Kassab Case Reports in Anesthesiology 2020 (1), 8767195, 2020 | 11 | 2020 |
| Genetic and immune profiling for potential therapeutic targets in adult human craniopharyngioma C Kassab, D Zamler, C Kamiya-Matsuoka, Z Gatalica, J Xiu, D Spetzler, ... Clinical oncology and research 2 (3), 2, 2019 | 10 | 2019 |
| Atypical presentation of parietal convexity dural-based cavernous hemangioma: a case report and review of literature F Bteich, C Kassab, G El Hage, R Moussa, GA Abadjian, R Bou-Nassif World Neurosurgery 128, 403-407, 2019 | 8 | 2019 |
| TMIC-60. Comprehensive spatial characterization of immune cells in the CNS brain tumor microenvironment C Kassab, D Zamler, P Gupta, V Srinivasan, G Rao, S Prabhu, J Huse, ... Neuro-oncology 21 (Supplement_6), vi261-vi261, 2019 | 5 | 2019 |
| Immunomodulatory Methods C Kassab, BP Kerrigan, H Caruso, S Al Enazy, AB Heimberger Nervous System Drug Delivery, 297-334, 2019 | 3 | 2019 |
| IMMU-35. TRANSCRIPTIONALLY DEFINED IMMUNE CONTEXTURE IN HUMAN GLIOMAS AT SINGLE-CELL RESOLUTION P Gupta, M Dang, K Bojja, H Shehwana, C Kamiya-Matsuoka, J Li, ... Neuro-oncology 22 (Supplement_2), ii112-ii112, 2020 | 2 | 2020 |
| Nervous System Drug Delivery: Principles and Practice RR Lonser, M Sarntinoranont, K Bankiewicz Academic Press, 2019 | 2 | 2019 |
| Immune landscape of a genetically-engineered murine model of glioma relative to human glioma by single-cell sequencing DB Zamler, T Shingu, LM Kahn, C Kassab, M Ott, K Tomczak, J Liu, Y Li, ... bioRxiv, 2020.05. 11.088708, 2020 | 1 | 2020 |
| Pediatric combined hepatocellular-cholangiocarcinoma (cHCC-CC) with neuroendocrine features: distinguishing genetic alterations detected by chromosomal microarray AB Wilhelm, AG Cunningham, C Kassab, EC Fitz, J Dong, ... Diagnostic pathology 18 (1), 20, 2023 | | 2023 |
| 1001 Immunophenotyping of brain tumors identifies interferon enriched phagocytes in human gliomas P Gupta, M Dang, D Hao, K Bojja, T Tran, H Shehwana, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
